Frontal fibrosing alopecia usually affects post-menopausal women. However, approximately 20% of female patients are pre-menopausal and 10% are men with distinctive presentation. Treatment options differ among patients and has to be individualized.

For further reading on treatment updates; refer to articles by Murad et al: (references in bibliography section)

​

1) JOURNAL EDITOR'S PICK OF THE YEAR 2018:

5 ALPHA‐REDUCTASE INHIBITOR TREATMENT FOR FRONTAL FIBROSING ALOPECIA: AN EVIDENCE‐BASED TREATMENT UPDATE. (JEADV)

​

2) REPLY TO EFFECTIVENESS OF DUTASTERIDE IN LARGE SERIES OF PATIENTS WITH FRONTAL FIBROSING ALOPECIA IN REAL CLINICAL PRACTICE. (JAAD)

​

3) FRONTAL FIBROSING ALOPECIA IN BREAST CANCER PATIENTS ON AROMATASE‐INHIBITOR. (JEADV)

​

4) PROSTAGLANDIN ANALOGUE FOR TREATMENT OF EYEBROW LOSS IN FRONTAL FIBROSING ALOPECIA: 3 CASES WITH DIFFERENT OUTCOMES. (JEADV)

​

5) WOOD’S LIGHT EXAMINATION FOR ASSESSMENT IN FRONTAL FIBROSING ALOPECIA: A MANOEUVRE TO ENHANCE THE HAIRLINE. (JAAD)